The Molecular Screening and Therapeutics (MoST) Program: A precision medicine framework for biomarker-driven signal-seeking clinical studies for rare cancers.

Dominique Hess,Lucille Sebastian,Katrin Marie Sjoquist,Chee Khoon Lee,Wendy Hague,Danielle Miller,Mark J. Cowley,Min-Ru Qiu,Stephen B. Fox,Anthony M. Joshua,John Simes,David Thomas

The Molecular Screening and Therapeutics (MoST) Program: A precision medicine framework for biomarker-driven signal-seeking clinical studies for rare cancers.

2017

Dominique Hess
Lucille Sebastian
Katrin Marie Sjoquist
Chee Khoon Lee
Wendy Hague
Danielle Miller
Mark J. Cowley
Min-Ru Qiu
Stephen B. Fox
Anthony M. Joshua
John Simes
David Thomas

TPS2621Background: Precision medicine aims to link molecular targets in tumors to cognate therapies and has the potential to yield new treatments for cancer patients with unmet clinical need. With ...

Keywords:

Precision medicine
Pathology
Biomarker (medicine)
Medicine
molecular targets
Cancer
Bioinformatics
molecular screening

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations